{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T14:59:22Z","timestamp":1775919562824,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Over the last two decades, several countries have initiated universal varicella vaccination (UVV) programs in infants. In 2019, the Swiss National Immunization Technical Advisory Group (NITAG) decided to start evaluating the introduction of universal varicella vaccination. There is a theoretical concern that suboptimal vaccination coverage could lead to a shift in the varicella incidence to older age groups, thereby potentially increasing complication rates. To achieve a high vaccination coverage rate, it is important that practicing physicians comply with a potential recommendation for UVV.<\/jats:p>\n                <jats:p>We studied the perception of varicella and the current vaccination behavior among Swiss pediatricians and general practitioners (GPs) who treat children. We also assessed their intention to advise parents to vaccinate their children against varicella in the event the Swiss NITAG will recommend UVV.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Primary data was collected through a structured, 20-min online survey with Swiss pediatricians and GPs who treat children.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>150 physicians participated in the study: 40 GPs in the German-speaking part, 20 GPs in the French-speaking part, 67 pediatricians in the German-speaking part, and 23 pediatricians in the French-speaking part.<\/jats:p>\n                <jats:p>The majority (64%) of all participants reported that they currently recommend varicella vaccination for risk groups according to the national immunization plan. About one third of physicians (35%) \u2013 predominantly pediatricians \u2013 currently already recommend it for all infants. In these situations, a measles, mumps, rubella, varicella combination vaccine is currently used by 58% for the first dose and by 59% for the second dose.<\/jats:p>\n                <jats:p>86% of participants stated that they would advise parents to have their children vaccinated against varicella in case of a recommendation for UVV by the Swiss NITAG. 68% responded that they expect many questions from parents and 65% agreed that they have good arguments to convey the importance of varicella vaccination.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The survey study results show that most participating pediatricians and GPs indicated a favorable attitude towards childhood vaccination against varicella in the setting of a Swiss NITAG recommendation for UVV. This data shows the importance of NITAG recommendations in influencing vaccine education and supporting achievement of high coverage of varicella vaccination.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-020-05586-3","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T18:03:54Z","timestamp":1609956234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Acceptance of universal varicella vaccination among Swiss pediatricians and general practitioners who treat pediatric patients"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9161-7107","authenticated-orcid":false,"given":"Florian","family":"Lienert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Heininger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrik","family":"Guggisberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"issue":"3","key":"5586_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1128\/CMR.9.3.361","volume":"9","author":"AM Arvin","year":"1996","unstructured":"Arvin AM. Varicella-zoster virus. Clin Microbiol Rev. 1996;9(3):361\u201381.","journal-title":"Clin Microbiol Rev"},{"issue":"9544","key":"5586_CR2","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","volume":"368","author":"U Heininger","year":"2006","unstructured":"Heininger U, Seward JF. Varicella. Lancet. 2006;368(9544):1365\u201376.","journal-title":"Lancet"},{"issue":"6","key":"5586_CR3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s00431-005-1637-8","volume":"164","author":"J Bonhoeffer","year":"2005","unstructured":"Bonhoeffer J, Baer G, et al. Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. Eur J Pediatr. 2005;164(6):366\u201370.","journal-title":"Eur J Pediatr"},{"key":"5586_CR4","volume-title":"Schweizerischer Impfplan","author":"Bundesamt f\u00fcr Gesundheit","year":"2020","unstructured":"Bundesamt f\u00fcr Gesundheit, Schweizerischer Impfplan 2020."},{"issue":"13","key":"5586_CR5","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1017\/S0950268817001546","volume":"145","author":"K Bollaerts","year":"2017","unstructured":"Bollaerts K, Riera-Montes M, et al. A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data. Epidemiol Infect. 2017;145(13):2666\u201377.","journal-title":"Epidemiol Infect"},{"issue":"34","key":"5586_CR6","doi-asserted-by":"publisher","first-page":"902","DOI":"10.15585\/mmwr.mm6534a4","volume":"65","author":"AS Lopez","year":"2016","unstructured":"Lopez AS, Zhang J, et al. Epidemiology of varicella during the 2-dose varicella vaccination program \u2014 United States, 2005\u20132014. MMWR Morb Mortal Wkly Rep. 2016 Sep 2;65(34):902\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"5586_CR7","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.4161\/hv.34426","volume":"10","author":"A Siedler","year":"2014","unstructured":"Siedler A, Dettmann M. Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany. Hum Vaccines Immunother. 2014;10(12):3594\u2013600.","journal-title":"Hum Vaccines Immunother"},{"key":"5586_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/INF.0000000000002233","volume":"38","author":"V Spoulou","year":"2019","unstructured":"Spoulou V, Alain S, et al. Implementing universal varicella vaccination in Europe. Pediatr Infect Dis J. 2019;38:181\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"5586_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4161\/hv.34311","volume":"11","author":"A Bechini","year":"2015","unstructured":"Bechini A, Boccalini S, et al. Impact of universal vaccination against varicella in Italy. Hum Vaccin Immunother. 2015;11(1):63\u201371.","journal-title":"Hum Vaccin Immunother."},{"issue":"2","key":"5586_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.vaccine.2013.11.008","volume":"32","author":"R Gil-Prieto","year":"2014","unstructured":"Gil-Prieto R, Walter S, et al. Different vaccination strategies in Spain and its impact on severe varicella and zoster. Vaccine. 2014 Jan;32(2):277\u201383.","journal-title":"Vaccine."},{"issue":"3","key":"5586_CR11","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1080\/21645515.2018.1546525","volume":"15","author":"FH Varela","year":"2019","unstructured":"Varela FH, Pinto LA, et al. Global impact of varicella vaccination programs. Hum Vaccin Immunother. 2019;15(3):645\u201357.","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"5586_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/oxfordjournals.aje.a117238","volume":"140","author":"ME Halloran","year":"1994","unstructured":"Halloran ME, Cochi SL, et al. Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol. 1994;140(2):81\u2013104.","journal-title":"Am J Epidemiol"},{"issue":"13","key":"5586_CR13","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.vaccine.2011.01.037","volume":"29","author":"AJ Van Hoek","year":"2011","unstructured":"Van Hoek AJ, Melegaro A, et al. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine. 2011 Mar 16;29(13):2411\u201320.","journal-title":"Vaccine"},{"key":"5586_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12879-016-1442-1","volume":"16","author":"A Van Lier","year":"2016","unstructured":"Van Lier A, Tostmann A, et al. Negative attitude and low intention to vaccinate universally against varicella among public health professionals and parents in the Netherlands: two internet surveys. BMC Infect Dis. 2016;16:127. https:\/\/doi.org\/10.1186\/s12879-016-1442-1.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"5586_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B (Methodological). 1995;57(1):289\u2013300.","journal-title":"J R Stat Soc B (Methodological)"},{"issue":"37\u201339","key":"5586_CR16","doi-asserted-by":"publisher","first-page":"6351","DOI":"10.1016\/j.vaccine.2006.05.029","volume":"24","author":"U Heininger","year":"2006","unstructured":"Heininger U. An internet-based survey on parental attitudes towards immunization. Vaccine. 2006;24(37\u201339):6351\u20135.","journal-title":"Vaccine"},{"issue":"52","key":"5586_CR17","doi-asserted-by":"publisher","first-page":"6700","DOI":"10.1016\/j.vaccine.2016.10.042","volume":"34","author":"P Paterson","year":"2016","unstructured":"Paterson P, et al. Vaccine hesitancy and healthcare providers. Vaccine. 2016 Dec 20;34(52):6700\u20136.","journal-title":"Vaccine."},{"key":"5586_CR18","doi-asserted-by":"publisher","first-page":"S203","DOI":"10.1016\/j.jpeds.2016.04.056","volume":"177S","author":"OG Jenni","year":"2016","unstructured":"Jenni OG, Sennhauser FH. Child health Care in Switzerland. Child health Care in Switzerland. J Pediatr. 2016;177S:S203\u201312.","journal-title":"J Pediatr"},{"key":"5586_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/jpc.13661","volume":"54","author":"NA Charania","year":"2018","unstructured":"Charania NA, Watson DG, et al. Perceptions of caregivers and providers regarding the potential introduction of the varicella vaccine to the childhood immunization schedule in New Zealand: a qualitative exploratory study. J Paediatr Child Health. 2018;54:28\u201335.","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"5586_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12879-017-2247-6","volume":"17","author":"L Vezzosi","year":"2017","unstructured":"Vezzosi L, Santagati G, et al. Knowledge, attitudes, and behaviors of parents towards varicella and its vaccination. BMC Infect Dis. 2017;17(1):172.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"5586_CR21","doi-asserted-by":"publisher","first-page":"476","DOI":"10.4161\/hv.26986","volume":"10","author":"T Rieck","year":"2014","unstructured":"Rieck T, et al. Vaccination coverage among children in Germany estimated by analysis of health insurance claims data. Hum Vaccin Immunother. 2014;10(2):476\u201384.","journal-title":"Hum Vaccin Immunother"},{"key":"5586_CR22","unstructured":"IQVIA Solutions. Healthcare Address-Guide (edition February 2020)."},{"key":"5586_CR23","volume-title":"Varicella vaccination in the European Union","author":"European Centre for Disease Prevention and Control","year":"2015","unstructured":"European Centre for Disease Prevention and Control. Varicella vaccination in the European Union. Stockholm: ECDC; 2015."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05586-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05586-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05586-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T04:36:05Z","timestamp":1609994165000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05586-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5586"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05586-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"7 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical review and approval were not required in accordance with the local legislation (Swiss federal law on research on humans, ). Participating physicians gave their written informed consent before filling out the online questionnaire (see additional file ).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"FL and PG are\u00a0former or current employees of MSD Merck Sharp & Dohme AG Switzerland, a manufacturer of varicella vaccines. The other authors declare that they have no competing interests and no honorarium was paid to UH or his institution.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}